Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | S100A6 |
Upstream (Parents) |
---|
(<<) S100A11 → S100A6 |
(<<) RAB25 → S100A6 |
(<<) LGALS3 → S100A6 |
Downstream (Children) |
---|
S100A6 → HBEGF (>>) |
S100A6 → S100A11 (>>) |
S100A6 → S100A2 (>>) |
S100A6 → SCEL (>>) |
S100A6 → MMP7 (>>) |
S100A6 → LAMC2 (>>) |
S100A6 → PHLDA2 (>>) |
S100A6 → EPS8L1 (>>) |
S100A6 → LPCAT4 (>>) |
S100A6 → PFKP (>>) |
S100A6 → C7orf44 (>>) |
S100A6 → MYOF (>>) |
S100A6 → S100A11P1///S100A11 (>>) |
S100A6 → DGKA (>>) |
S100A6 → LIF (>>) |
S100A6 → FHL2 (>>) |
S100A6 → MALL (>>) |
S100A6 → ITGA3 (>>) |
S100A6 → SERPINB1 (>>) |
S100A6 → LGALS3 (>>) |
S100A6 → ITGB4 (>>) |